Delivery Order SPE2DB25D3017-SPE2DB25FVKAG
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $103K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $80,243.07 to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (quantity 28) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mifepristone 300 mg tablets in a 28-day supply quantity, with a ceiling value of $84,653.44. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Mifepristone 300 mg tablets (28-count) with a ceiling value of $69,408.71. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of mifepristone 300 mg tablets, a medication used for certain medical purposes. The contract has a ceiling value of $81,104.15 and is a firm-fixed-price contract. The contract is not set-aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.00 firm fixed-price delivery order is for the supply of MIFEPREX 200 MG tablets. The award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a $3,364.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on August 22, 2025, with an ultimate completion date of August 25, 2025. The delivery order covers Myfembree 40 mg–1 mg–0.5 mg tablets in a 28-day supply, a hormonal contraceptive medication. This is a non-set-aside competitive award issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.64 to AmerisourceBergen Drug Corp for Levonorgestrel 1.5 mg tablets on September 12, 2025, with completion scheduled for September 15, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.15 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone-based pharmaceutical product. This non-competitive delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Liletta 52 mg contraceptive systems valued at $2,349.50 with a firm fixed price structure. This non-set-aside delivery order was issued on November 4, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cryselle-28 tablets (a contraceptive medication) under a firm fixed-price contract structure. The award, valued at $1,643.68, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion prime vendor agreement running through December 2026. The delivery order carries no...